Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 19.57 USD -1.21% Market Closed
Market Cap: 6.9B USD
Have any thoughts about
Bausch + Lomb Corp?
Write Note

Gross Margin
Bausch + Lomb Corp

60.9%
Current
60%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60.9%
=
Gross Profit
2.9B
/
Revenue
4.7B

Gross Margin Across Competitors

Country CA
Market Cap 6.9B USD
Gross Margin
61%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Country CH
Market Cap 37.9B CHF
Gross Margin
55%
Country DK
Market Cap 200.9B DKK
Gross Margin
68%
Country US
Market Cap 16.9B USD
Gross Margin
70%
Country KR
Market Cap 9.9T KRW
Gross Margin
15%
Country CN
Market Cap 48.6B CNY
Gross Margin
73%
Country US
Market Cap 6.3B USD
Gross Margin
65%
Country US
Market Cap 6.1B USD
Gross Margin
47%
Country UK
Market Cap 4.8B GBP
Gross Margin
56%
Country CH
Market Cap 4.9B CHF
Gross Margin
35%
No Stocks Found

Bausch + Lomb Corp
Glance View

Market Cap
6.9B USD
Industry
Health Care

Bausch + Lomb Corp., a subsidiary of Bausch Health Companies Inc., is a global leader in the eye health sector, dedicated to enhancing the vision and overall well-being of individuals worldwide. With a history spanning over 160 years, the company has built a robust portfolio that includes contact lenses, lens care products, and surgical devices. Their commitment to innovation is evident in their continuous investment in research and development, which has led to breakthrough technologies, such as advanced ocular surgical instruments and solutions that improve the quality of life for patients with vision impairments. As the global population ages and the demand for eye care products increases, Bausch + Lomb is well-positioned to capitalize on these trends, making it an appealing consideration for investors seeking growth in a stable, essential market. In addition to its innovative product offerings, Bausch + Lomb benefits from a strong brand reputation and a well-established distribution network, allowing it to reach millions of customers across diverse markets. The company's focus on expanding its market share through strategic partnerships and acquisitions adds a layer of potential for revenue growth. Investors should note that eye health is a critical aspect of healthcare, making Bausch + Lomb's mission not only significant but also potentially lucrative. As the company navigates the evolving landscape of the health and wellness industry, its strategic focus on eye care uniquely positions it as a reliable investment opportunity for those looking to strengthen their portfolios with a company that marries tradition with modernity in a timeless sector.

BLCO Intrinsic Value
26.53 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60.9%
=
Gross Profit
2.9B
/
Revenue
4.7B
What is the Gross Margin of Bausch + Lomb Corp?

Based on Bausch + Lomb Corp's most recent financial statements, the company has Gross Margin of 60.9%.